Zhejiang Jingxin Pharmaceutical Co Ltd
-
Dimdazenil Capsules Approved for Marketing by China NPMA for Short Term Treatment of Insomnia Disorders
Nov, 2023. Class 1 innovative drug Dimdazenil Capsules from Zhejiang Jingxin Pharmaceutical Co., Ltdis approved for marketing by China NPMA for short term treatment of insomnia disorders.
